Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Self-Evaluation: Self-Enhancement and Self-Verification

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...

Muscle Recovery and Fatigue

Muscle Recovery and Fatigue

Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective...

Bioavailability Enhancement: Drug Solubility Enhancement

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...

Bioavailability Enhancement: Drug Permeability Enhancement

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Bioavailability Enhancement: Drug Stability Enhancement and GI Retention

Body:Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...

Modified-Release Drug Delivery Systems: Rate-Programmed II

Modified-Release Drug Delivery Systems: Rate-Programmed II

Rate-programmed drug delivery systems release drugs in a controlled manner to maintain therapeutic levels. Three main designs include reservoir, matrix, and hybrid systems.Reservoir systems consist of a drug core enclosed within a membrane that controls drug release. In non-swelling reservoir systems, polymers like ethyl cellulose or polymethacrylates are used. These do not hydrate in aqueous media and control release through membrane thickness, porosity, or insolubility. This type includes...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying Patients with Colorectal Cancer Likely to Benefit from a Trimodal Prehabilitation Prior to Surgery.

Nutrients·2026

Same author

Adaptation and validation of the cancer awareness measure tool for individuals with intellectual disabilities in Hungary.

Frontiers in public health·2026

Same author

Risk Factors and Clinical Severity in Chronic Venous Disease: A New Look.

International journal of dermatology·2026

Same author

Correction: Bridging healthcare disparities: a systematic review of healthcare access for disabled individuals in rural and urban areas.

Frontiers in health services·2026

Same author

Bridging healthcare disparities: a systematic review of healthcare access for disabled individuals in rural and urban areas.

Frontiers in health services·2025

Same author

Enhancing resilience and mental well-being among paediatric nurses: a systematic review of effective strategies and implementation challenges.

European journal of pediatrics·2025

Search research articles

Related Experiment Video

Updated: Feb 13, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants

Enhanced Oil Recovery using a Combination of Biosurfactants

Published on: June 3, 2022

[Enhanced Recovery Program in colorectal surgery].

Balázs Bánky¹, Miklós Lakatos¹, Krisztina Varga¹

¹Sebészeti Osztály, Szent Borbála Kórház 2800 Tatabánya, Dózsa Gy. út 77.

Magyar Sebeszet

|March 15, 2018

Summary

The Enhanced Recovery After Surgery (ERAS) program significantly reduced hospital stays and complications in colorectal surgery patients. This evidence-based strategy proved effective and safe for widespread adoption in county hospitals.

Keywords:

ERAS colorectal colorectalis kezelés multidisciplinary multidiszciplináris perioperative perioperatív

More Related Videos

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Orthotopic Mouse Model of Colorectal Cancer

Orthotopic Mouse Model of Colorectal Cancer

Published on: December 4, 2007

Related Experiment Videos

Last Updated: Feb 13, 2026

Enhanced Oil Recovery using a Combination of Biosurfactants

Enhanced Oil Recovery using a Combination of Biosurfactants

Published on: June 3, 2022

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

Orthotopic Mouse Model of Colorectal Cancer

Orthotopic Mouse Model of Colorectal Cancer

Published on: December 4, 2007

Area of Science:

Colorectal Surgery
Perioperative Care
Evidence-Based Medicine

Background:

The Enhanced Recovery After Surgery (ERAS) program is a well-established, evidence-based strategy in perioperative colorectal patient management.
ERAS, particularly when combined with laparoscopy, is known to reduce morbidity, hospital stay, and costs.

Purpose of the Study:

To report a retrospective clinical audit of an ERAS program implemented in a county hospital.
To compare the clinical outcomes of traditional perioperative colorectal management with the ERAS protocol.

Main Methods:

A retrospective audit was conducted over two years (2015-2016).
Clinical results of 130 patients under traditional protocols were compared with 84 patients managed under the ERAS protocol.
Patients were assessed based on demographic, cancer-related, and clinical outcome parameters.

Main Results:

The ERAS group had a shorter median hospital stay (6 days) compared to the traditional group (8 days).
Morbidity (Clavien-Dindo grade ≥2) was significantly lower in the ERAS group (8.3%) versus the traditional group (27.4%).
The ERAS program achieved a success rate of over 70% for discharge by the 7th postoperative day, with no increase in readmission rates.

Conclusions:

The ERAS program was successfully introduced and implemented in a Middle-Eastern European county hospital's colorectal service.
Favorable outcomes from the audit led to the adoption of the ERAS protocol as the primary perioperative scheme for all elective colorectal cases starting in 2017.